AI Specialist Chai Discovery Raises $400m

Chai Discovery raises $400M as AI drug discovery booms

Chai Discovery’s $400m raise triples its value to $3.8bn in seven months. It is the latest sign that AI drug discovery has moved from promise to deployment. AI drug discovery just minted another fast-rising star. Chai Discovery has raised a $400m Series C that values the San Francisco startup at $3.8bn, the company said. That […] This story continues at The Next Web

AI specialist Chai Discovery raises $400m

Fresh from an alliance with Novartis, Chai Discovery has raised $400 million in third-round funding for its AI-based molecular design platform.

Chai Discovery triples to $3.8B in 7 months as OpenAI-backed drug designer lands $400M after Novartis deal

Chai Discovery raised $400 million at a $3.8 billion valuation, tripling its worth in seven months and pushing total funding above $600 million across three rounds in eleven months. The round lands a day after Chai announced a collaboration with Novartis, giving it Pfizer, Eli Lilly, and Novartis as pharma partners simultaneously. Index Ventures led the round; new backers include Bain Capital Ventures, Battery Ventures and Baillie Gifford, along…

Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma

Chai Discovery Inc., a company that develops artificial intelligence models to predict interactions between biochemical molecules, today announced it has raised $400 million in Series C funding, nearly tripling its valuation to $3.8 billion. Index Ventures led the round alongside Kleiner Perkins, Sequoia Capital and Dimension. New investors joining the investment included Bain Capital Ventures, […] The post Chai Discovery nabs $400M Series C as …

Chai Discovery gets $400M, tripling valuation from seven months ago

Chai Discovery, one of the hottest startups in the AI-generated drug discovery landscape, has corralled $400 million in a Series C that triples its paper value from its last round of financing. In December, Chai ...

Chai Discovery Raises $400M to Accelerate AI-Driven Molecular Design Platform

What You Should Know Structural biology and AI drug design pioneer Chai Discovery has announced a $400M Series C funding round, valuing the company at $3.8 billion just two years after its 2024 founding.The heavily oversubscribed round was led by Index Ventures, alongside Kleiner Perkins, Sequoia Capital, and Dimension, with strategic backing from existing investors OpenAI and Thrive Capital.Moving past legacy computational screening methods, Ch…